A premier network of high-performing clinical trial sites
A successful study start-up relies on a host of critical factors. According to Tufts Center for Drug Development, 80 percent of delayed trials are often related to patient recruitment, and 48% of sites miss their targets. These realities are forcing biopharmaceutical firms to re-examine how they execute study start-up.
IQVIA can help you get your study off to a fast start.
From the very beginning, you have opportunities to set up your study for success. Start-up delays and late completions don’t have to be part of your clinical development story.
Let us help you accelerate and optimize your study’s start-up.
A premier network of high-performing clinical trial sites
Proven clinical research networks to accelerate drug development
Precise, predictable, and efficient clinical trial recruitment
Recruit and retain the right patients – faster
Targeted solutions to support your research